Latest news about Mangalam Organics
Mangalam Organics
431.00
+6.95(+1.64%)
Company Performance:
View Company Insights1D+1.64%
1M-7.60%
6M+0.63%
1Y-17.70%
5Y-52.50%
More news about Mangalam Organics
30Jul 26
Mangalam Organics consolidated profit falls 41% in Q1FY27 despite revenue growth
Mangalam Organics Limited reported a significant divergence between top-line growth and bottom-line profitability for Q1FY27. Consolidated net profit fell 41% YoY to ₹7.27 crore despite a 22% rise in revenue to ₹179.09 crore. EBITDA margins contracted to 12.40% from 14.74%, indicating margin compression. Standalone profits also declined 23% YoY to ₹5.32 crore.
30Jul 26
Mangalam Organics Q1FY27 profit falls 23% as material costs rise
Mangalam Organics Limited saw its Q1FY27 standalone net profit fall 22.6% to ₹6.38 lakh due to rising material costs outpacing revenue growth of 43.5%. Consolidated profits dropped 40.5% to ₹8.70 lakh. The company also announced the appointment of M/s JMT & Associates as statutory auditors and scheduled its 44th AGM for late September 2026.
04Jul 26
Mangalam Organics files ₹12.58 Cr claim for Khopoli plant fire loss
Mangalam Organics Ltd has filed an insurance claim of ₹12.58 Cr with The New India Assurance Company Limited following a fire at its Khopoli plant on July 16, 2025. The appointed Insurance Surveyor completed the loss assessment and submitted the final report. While the company is pursuing settlement, no funds have been realized as of July 03, 2026.
02Jul 26
Mangalam Organics appoints Manoj Mhapadi as CFO effective July 01, 2026
Mangalam Organics Ltd appointed Manoj Mhapadi as Chief Financial Officer effective July 01, 2026, following the retirement of Mr. Shrirang Rajule. The company updated the list of officials authorized to determine materiality and make disclosures under SEBI regulations.
24Jun 26
Mangalam Organics appoints Manoj Mhapadi as CFO from July 1
Mangalam Organics Ltd has appointed Manoj Mhapadi as its Chief Financial Officer (CFO) and Key Managerial Personnel effective July 1, 2026, succeeding Shrirang V. Rajule who retires on June 30, 2026. The Board approved the appointment based on committee recommendations. Additionally, the Board appointed Mr. Vilaskumar Vaghela as Internal Auditor and M/s. NKJ & Associates as Cost Auditor for the Financial Year 2026-27.
02Jun 26
Mangalam Organics FY26 profit surges on higher revenue
Mangalam Organics Limited reported a consolidated net profit of ₹25.38 crore for FY26, up from ₹12.50 crore in FY25, with revenue rising to ₹622.57 crore. The board approved the audited results on May 29, 2026, and an investor presentation was released on June 1, 2026. The financials include an exceptional loss of ₹3.50 crore due to an insurance claim reversal and write-offs of inter-corporate loans.
21May 26
Mangalam Organics Promoters Hold 50.2 Lakh Shares in FY26
Mangalam Organics Limited filed its annual disclosure for FY26, stating the Promoter and Promoter Group hold 50,22,926 equity shares. The company confirmed no encumbrances were made on these shares during the financial year ended March 31, 2026.
14Apr 26
Mangalam Organics Receives CRISIL Rating Reaffirmation on Rs.397 Crore Bank Facilities
Mangalam Organics Limited received rating reaffirmation from CRISIL on bank facilities worth Rs.397 crore. The agency maintained BBB+/A2 ratings with Watch Developing status, continuing 'Rating Watch with Developing Implications'. Facilities are distributed across YES Bank, HDFC Bank, Axis Bank, and Saraswat Co-Operative Bank, including cash credit, letters of credit, and term loans.
06Apr 26
Mangalam Organics Submits SEBI Compliance Certificate for Q4FY26
Mangalam Organics Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4FY26 ended March 31, 2026. The certificate from registrar MUFG Intime India Private Limited confirms proper dematerialization processes, timely substitution of depository names in records, and adherence to prescribed timelines for security certificate processing during the quarter.
14Feb 26
Mangalam Organics Releases Q3FY26 Investor Presentation Under SEBI Regulations
Mangalam Organics Limited has submitted its investor presentation for Q3FY26 to stock exchanges under SEBI regulations. The company reported consolidated revenue growth of 32.59% to Rs 16,429.84 lakhs, while standalone operations showed revenue increase of 21.81% to Rs 12,244.57 lakhs with declining net profit.
07Jan 26
Vijay Kedia's firm sells 1.38 lakh Mangalam Drugs shares worth ₹48.35 lakh in bulk deal
Mangalam Drugs & Organics experienced multiple bulk deals on Wednesday, with Vijay Kedia's firm Kedia Securities selling 1.38 lakh shares worth ₹48.35 lakh alongside other institutional sellers. Despite the selling pressure, the stock gained 5% to ₹35.18, continuing a recent recovery that has seen 40% gains over the past month, though it remains 69% down over the past year. The company reported a net loss of ₹7.40 crore for Q2 FY26 compared to a ₹2.70 crore profit in the previous year, with revenue declining 38% to ₹50.00 crore.
30Dec 25
Mangalam Drugs Hits Upper Circuit After Vijay Kedia's ₹33.27 Lakh Investment
Vijay Kedia's ₹33.27 lakh investment in Mangalam Drugs & Organics triggered strong market response, with the stock zooming over 10% in two days and hitting upper circuit at ₹26.28. Despite the recent rally, the pharmaceutical stock remains down 77.77% over twelve months, making this a contrarian bet by the veteran investor.
17Nov 25
Mangalam Organics Reports 14.30% Revenue Growth in Q2 FY26, Driven by B2B-to-B2C Transformation
Mangalam Organics, a manufacturer of pine chemicals and camphor-based products, reported a 14.30% year-on-year revenue growth for Q2 FY26, reaching Rs 158.10 crores. The company's profitability improved due to decreased input costs. Mangalam Organics is strategically shifting from B2B to include B2C operations, focusing on its CamPure brand of camphor-based home care products. The company has expanded its distribution network to 14 states with a sales force of 190 personnel. While EBITDA decreased significantly, PAT increased by 50.94% year-over-year.
17Sept 25
Mangalam Organics Secures ₹50 Crore Loan Facility from Yes Bank, Cancels NCD Issuance Plan
Mangalam Organics has executed a loan facility agreement with Yes Bank for ₹50 crore, cancelling its previous plan to issue non-convertible debentures. The loan includes ₹48 crore in working capital limits and a ₹2 crore unsecured forward cover limit. The funds will be used for working capital, capital expenditure for camphor plant reinstatement, and general working capital needs. The loan is secured by hypothecation of assets and personal guarantees. This move is expected to support the company's operations and production capabilities.
12Sept 25
Mangalam Organics to Hold Board Meeting on Fundraising Proposal
Mangalam Organics Limited has announced a board meeting for September 16, 2025, to consider and approve proposals for raising funds from banks or financial institutions. The company has closed the trading window for designated persons from September 12, 2025, until 48 hours after the meeting outcome is made public, in compliance with SEBI regulations.
05Sept 25
Mangalam Organics Reports Q1 FY2021 Results Amid COVID-19 Challenges
Mangalam Organics announced unaudited financial results for Q1 FY2021 ending June 30, 2020. The company's operations were significantly impacted by COVID-19 lockdowns, leading to plant and office shutdowns. A phased resumption of operations began in April 2020. The company's assessment concluded no adjustments were needed in the financial statements. The Board of Directors approved the results, which were submitted to the stock exchange with a Limited Review Report from NGST & Associates.
18Aug 25
Mangalam Organics Secures INR 60 Crore Through Private Placement of NCDs
Mangalam Organics' Board has approved the issuance of Non-Convertible Debentures (NCDs) worth up to INR 60 crores through private placement. The secured, unlisted NCDs offer a 12.50% annual interest rate, with a 36-month tenure and monthly coupon payments. Principal repayment starts after a 15-month moratorium. The NCDs are secured by first pari-passu charge on fixed assets and personal guarantees from key executives.
09Aug 25
Mangalam Organics Reports Strong Q1 Results with 632% PAT Growth
Mangalam Organics, a leading manufacturer of terpene and rosin derivatives, reported robust Q1 FY24 results. Revenue increased by 24.2% to ₹146.55 crores, EBITDA nearly doubled to ₹21.6 crores, and PAT surged by 632.30% to ₹12.23 crores. The company's performance was driven by decreased input costs, improved operational efficiency, and strong market demand. Mangalam Organics operates in B2B (96% of revenue) and B2C segments, focusing on terpene products, synthetic resins, and homecare products. The company is pursuing strategic initiatives including product portfolio expansion, geographical reach extension, e-commerce focus, and exploring new export opportunities in the USA and UK.
08Aug 25
Mangalam Organics Reports Q1 Results, Schedules AGM, and Announces Key Appointments
Mangalam Organics Limited reported robust Q1 financial results with revenue from operations increasing by 24.2% year-over-year to ₹14,655.39 lakhs. Profit before tax grew by over 600% to ₹1,468.70 lakhs. The company scheduled its 43rd AGM for September 16 and announced re-appointment of key directors. New auditor appointments were made, including Internal Auditor, Cost Auditor, and Secretarial Auditor. The company also approved amendments to its Insider Trading Policy. A fire incident occurred at the Camphor Plant on July 16, but the company is working to augment production through Camphor Plant-II.
Industry Peers
Deepak Fertilisers & Petrochemicals
Tata Chemicals
Gujarat Narmada Valley Fert & Chem
TANFAC Industries
Gujarat Alkalies & Chemicals
Grauer & Weil
GHCL
Chemplast Sanmar
JG Chemicals
Fischer Medical Ventures
1,389.00
(-0.64%)
631.30
(-0.89%)
580.50
(-2.27%)
3,360.65
(+5.10%)
594.10
(-1.02%)
78.40
(-0.87%)
384.95
(-0.25%)
209.74
(+1.75%)
632.85
(-1.73%)
30.22
(+1.04%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
